Cannabis extract relieved neuropathic pain in rats comparably to gabapentin
Two cannabis extracts showed pain-relieving effects comparable to gabapentin in a rat neuropathic pain model, with complex effects on CB1 and CB2 receptor expression that varied by brain region and dose.
Quick Facts
What This Study Found
Cannabis extracts demonstrated antinociceptive effects comparable to gabapentin in vincristine-induced neuropathic pain. CB1R protein expression increased in hippocampus with both extracts but decreased in cortex. CB2R expression increased in hippocampus and cortex with extract B. Receptor changes alone did not fully explain behavioral effects.
Key Numbers
130 rats. Gabapentin 60 mg/kg reference dose. Extract D doses: 10, 20, 40 mg/kg. Extract B doses: 5, 7.5, 10, 20 mg/kg. Pain relief comparable to gabapentin.
How They Did This
130 male Wistar rats divided into groups receiving vincristine (to induce neuropathic pain), gabapentin, or two cannabis extracts (D and B) at various doses. CB1R and CB2R mRNA and protein expression measured in cortex, hippocampus, and lymphocytes. Behavioral tests: Tail-Flick and von Frey.
Why This Research Matters
Neuropathic pain is notoriously difficult to treat, and gabapentin is a first-line therapy with significant side effects. Finding that cannabis extracts match gabapentin's pain relief with different side effect profiles could offer patients alternatives.
The Bigger Picture
The finding that cannabinoid receptor changes did not fully explain pain relief suggests cannabis extracts work through additional pathways beyond the endocannabinoid system, which could include anti-inflammatory, GABAergic, or serotonergic mechanisms.
What This Study Doesn't Tell Us
Rat model with vincristine-induced neuropathy may not replicate human neuropathic pain. Only male rats studied. Specific cannabinoid composition of extracts not fully characterized. Cannot translate doses directly to humans.
Questions This Raises
- ?Which additional signaling pathways contribute to cannabis extract pain relief?
- ?Would similar efficacy be seen in other neuropathic pain models or in human trials?
Trust & Context
- Key Stat:
- Pain relief comparable to gabapentin
- Evidence Grade:
- Controlled animal study with behavioral and molecular endpoints, but limited human translatability.
- Study Age:
- 2024 rat study of cannabis extracts for vincristine-induced neuropathic pain
- Original Title:
- Cannabis sativa L. Extract Alleviates Neuropathic Pain and Modulates CB1 and CB2 Receptor Expression in Rat.
- Published In:
- Biomolecules, 14(9) (2024)
- Authors:
- Bartkowiak-Wieczorek, Joanna, Bienert, Agnieszka, Czora-Poczwardowska, Kamila, Kujawski, Radosław, Szulc, Michał, Mikołajczak, Przemysław, Wizner, Anna-Maria, Jamka, Małgorzata, Hołysz, Marcin, Wielgus, Karolina, Słomski, Ryszard, Mądry, Edyta
- Database ID:
- RTHC-05119
Evidence Hierarchy
Frequently Asked Questions
Is cannabis as effective as gabapentin for nerve pain?
In this rat study, cannabis extracts showed comparable pain relief to gabapentin. However, animal results do not directly translate to humans, and clinical trials in people are needed to confirm this comparison.
How do cannabis extracts relieve pain?
The study found changes in cannabinoid receptor expression but noted these did not fully explain the pain relief, suggesting additional signaling pathways beyond the endocannabinoid system contribute to the effect.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-05119APA
Bartkowiak-Wieczorek, Joanna; Bienert, Agnieszka; Czora-Poczwardowska, Kamila; Kujawski, Radosław; Szulc, Michał; Mikołajczak, Przemysław; Wizner, Anna-Maria; Jamka, Małgorzata; Hołysz, Marcin; Wielgus, Karolina; Słomski, Ryszard; Mądry, Edyta. (2024). Cannabis sativa L. Extract Alleviates Neuropathic Pain and Modulates CB1 and CB2 Receptor Expression in Rat.. Biomolecules, 14(9). https://doi.org/10.3390/biom14091065
MLA
Bartkowiak-Wieczorek, Joanna, et al. "Cannabis sativa L. Extract Alleviates Neuropathic Pain and Modulates CB1 and CB2 Receptor Expression in Rat.." Biomolecules, 2024. https://doi.org/10.3390/biom14091065
RethinkTHC
RethinkTHC Research Database. "Cannabis sativa L. Extract Alleviates Neuropathic Pain and M..." RTHC-05119. Retrieved from https://rethinkthc.com/research/bartkowiak-wieczorek-2024-cannabis-sativa-l-extract
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.